Search Results
Jul 01, 2026, 23:16 ET S-CELL好細胞推出創新內源性GLP-1合生元補充劑，由嗜黏蛋白阿克曼菌P9信號技術與CoreBiome®技術驅動，無需注射
香港2026年7月2日 /美通社/ -- 細胞健康與抗衰生物科技頂尖創新企業S-CELL好細胞今日宣布推出全新代謝調節合生元（益生元與益生菌）補充劑。這一開創性配方代表體重管理的範式轉變，核心作用機制為激活人體自身天然生成胰高糖素樣肽-1(GLP-1)。 腸道微生物組是人體健康的根基。人體免疫系統、大腦、心臟、骨骼、肌肉及皮膚狀態均受腸道菌群的影響。[1]事實上，腸道健康還會影響情緒、膚質、髮質，甚至睡眠質量
More news about: S-CELL
Jul 01, 2026, 19:05 ET Siddharth Mittal Appointed as Managing Director & CEO of Syngene International
commercial operations, expanding its presence across global markets, securing key regulatory approvals and successfully commercializing Biocon's GLP-1 portfolio across major international markets. He also led strategic partnerships and commercial initiatives that strengthened Biocon's competitive
More news about: Syngene International
Jul 01, 2026, 10:44 ET Parker Waichman LLP Files Lawsuits on behalf of Georgia and California Residents Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic
Waichman continues to file additional cases and urges individuals who have suffered serious eye injuries after taking these widely prescribed GLP-1 receptor agonist medications to contact them for a
More news about: Parker Waichman LLP
Jul 01, 2026, 08:53 ET Coalition for Metabolic Health Launches First in Series of Congressional Briefings on Nutrition and Chronic Disease
can help address chronic disease and reduce healthcare costs in the United States. This initial session explored nutrition and health in the era of GLP-1s. Co-sponsored by Rep. Lloyd Smucker (PA-11) and Rep. Sharice Davids (KS-03), the briefing brought together members of Congress,
More news about: Coalition for Metabolic Health
Jul 01, 2026, 08:00 ET New Medicare GLP-1 Bridge Program Could Help More People Access Obesity Care
/PRNewswire/ -- The Obesity Action Coalition (OAC) welcomes the start of the Medicare GLP-1 Bridge, a short-term program that may help eligible Medicare Part D beneficiaries access certain GLP-1 medications for obesity care at a $50 monthly copay. For many people living with
More news about: Obesity Action Coalition
Jul 01, 2026, 07:00 ET Wegovy® is now accessible to eligible Medicare beneficiaries living with obesity through Medicare GLP-1 Bridge
supply.† Once approved, refills do not require a new prior authorization as long as you stay on the same GLP-1 medication.The Medicare GLP-1 Bridge provides eligible patients access to Wegovy® specifically for weight management. It is important to
More news about: Novo Nordisk
Jun 30, 2026, 13:47 ET FDA Sets Peptide Impurity Thresholds as Low as 0.10%, Oath Research Analysis Finds
should reflect.The practical relevance for researchers is that most commonly studied peptides, including growth hormone secretagogues, GLP-1 analogs, and repair peptides, fall within the 40 amino acid classification. That means the FDA's drug-framework impurity standards, detailed in
More news about: Oath Research
Jun 30, 2026, 10:43 ET Long-Acting Drugs Market to Reach US$ 13.3 Billion by 2033 Expands Amid Advances in Sustained Drug Delivery and Chronic Disease Management - Persistence Market Research
alternatives to injectable GLP-1 therapies. Eli Lilly stated that orforglipron is a once-daily oral small-molecule GLP-1 receptor agonist designed without food and water intake restrictions, differentiating it from existing oral GLP-1 treatments. In one Phase III study,
More news about: Persistence Market Research Pvt. Ltd.
Jun 30, 2026, 10:30 ET UFC GYM, NexGen MD Scientific Launch PWR Clinics and Expansion of Longevity Clinic Network
gym brands nationwide.The PWR model delivers medically supervised longevity services, including peptide therapy, GLP-1 programs, hormone replacement therapy (HRT), testosterone replacement therapy (TRT), IV therapy, and aesthetic treatments including Botox and fillers.
More news about: NexGen MD Scientific; UFC GYM
Jun 30, 2026, 08:00 ET The Buyback Pays Off: Withings Confirms Full-Year Profitability for 2025, Driven by U.S. Market Dominance
from consumer gadgetry toward clinical grade prevention. In 2026, as the American healthcare conversation reorients around longevity, the GLP-1 era, and the expansion of remote patient monitoring, that bet has aligned alongside the market."Longevity, prevention, and at-home monitoring
More news about: Withings
Jun 30, 2026, 07:43 ET KidneyIntelX® Delivers Unprecedented Two-Year Real-World Outcomes in Diabetic Kidney Disease: No Comparable Risk Assessment Tool Exists
Mount Sinai. Combination SGLT2 inhibitor and GLP-1 receptor agonist therapy in high-risk patients nearly tripled, rising from 12% to 32% over the same period.Patients who started SGLT2i or GLP-1 RA therapies had nearly double the odds (OR 1.93)
More news about: Renalytix
Jun 29, 2026, 13:56 ET Better Care and Lower Costs: The Provider-Aligned Model of Care
savings.HealthPartners reduced weight-loss drug cost trends by 32 percent through a personalized diabetes management program for members using GLP-1 medications.Jefferson Health Plans cut avoidable hospital readmissions, generating an estimated $1 million to $1.25 million in savings
More news about: Alliance of Community Health Plans
Jun 29, 2026, 10:08 ET The Best Spine Surgery Is the One You Never Need: Harvard-Trained Spine Surgeon Releases Landmark Book on Preventing Chronic Low Back Pain
chronic disability. The book also reviews current concepts in weight management, including calorie control, exercise physiology, protein intake, GLP-1 medications, sleep optimization, and long-term behavioral change.A major focus of the book is the often-overlooked sacroiliac joint, a significant
More news about: PML Mastery
Jun 29, 2026, 08:35 ET From Fiber to Flavor: The Vitamin Shoppe Unveils Five Defining Trends Shaping the Next Era of Health and Wellness
driven by TikTok's "fibermaxxing" trend, expanding consumer awareness of the gut microbiome, and increasing interest in metabolic health and GLP-1 nutrition. Fiber category sales at The Vitamin Shoppe have increased 20% year-to-date, while searches for "fiber" have risen 59% and "psyllium husk"
More news about: The Vitamin Shoppe
Jun 25, 2026, 14:00 ET Epigenetic Clocks vs. VO₂ Max: How Do You Actually Prove a Longevity Treatment Is Working? Healthi Life Analysis Explores Which Biomarkers Hold Up Under Placebo-Controlled Scrutiny
outcome.GLP-1 Peptides and the Strongest RCT Evidence to DateThe most methodologically rigorous evidence linking a peptide to epigenetic age reduction comes not from growth hormone secretagogues but from a GLP-1 receptor agonist. A 2025 double-blind,
More news about: Healthi Life
Jun 25, 2026, 13:31 ET TrialScreen Inc., Bectas Therapeutics Inc. Recognized as Top Innovators as DIA 2026 Charts the Course Ahead
health regulators from every continent with industry leaders to take on a variety of topics, including AI governance in drug development, the future of GLP-1s for treating multiple conditions, and engineered cell therapies.The event also spotlighted the LIFT Series, a first-of-its-kind platform connecting
More news about: Drug Information Association
Jun 25, 2026, 12:20 ET Parker Waichman LLP Files Lawsuit on behalf of Ohio Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic
file additional cases and urges individuals who have suffered serious eye injuries after taking these widely prescribed GLP-1 receptor agonist medications to contact them for a
More news about: Parker Waichman LLP
Jun 25, 2026, 08:33 ET Black Girl Wellness Fest Makes Its Highly Anticipated Chicago Debut: Meagan Good, Ta'Rhonda Jones, Dr. Contessa Metcalf and Top Wellness Voices Headline a Powerful Day of Wellness, Thousands of Women Expected to Attend
reproductive education, youth empowerment, self-care, and community healing.Dr. Contessa Metcalf will join a panel on GLP-1 medications and the future of metabolic health.SCHOLARSHIP GIVINGAs part of its broader mission to close the health equity
More news about: Black Girl Vitamins
Jun 25, 2026, 06:45 ET What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management
regarding the Medicare GLP-1 Bridge* program taking effect July 1, 2026. Under the program, Medicare Part D patients may be able to access Foundayo (orforglipron) or Zepbound (tirzepatide) KwikPen for single-patient-use for weight management. The Medicare GLP-1 Bridge program will be
More news about: Eli Lilly and Company
Jun 24, 2026, 16:15 ET CIR-0602K Begins Dosing in Breakthrough T1D-Supported Phase 2 in Type 1 Diabetes
beneficial shifts in adipose tissue phenotype ("bad fat" to "good fat"), both alone and on top of GLP-1 and GLP-1/GIP agonists. In combination with GLP-1/GIP dual agonist tirzepatide, the synergistic transformation of subcutaneous adipose tissue includes dramatic
More news about: Cirius Therapeutics
Jun 24, 2026, 09:04 ET PLT Wants Attendees to 'Feel the Science' with Disruptive Beverage-Friendly Ingredients at IFT First 2026
Control that can serve as a complementary solution for brands looking at healthy eating behaviors and weight management trends adjacent to the GLP-1 category.According to Steve Fink, PLT's Vice President of Marketing, consumer experience is becoming a critical factor for product success—especially
More news about: PLT Health Solutions
Jun 24, 2026, 08:36 ET HKeyBio Launches NHP Fast-Tox Program for Accelerating Non-GLP NHP Safety Risk Screening
generates decision-relevant exploratory data before larger GLP studies are initiated.Non-GLP NHP Toxicology as an Early Risk-Management ToolHKeyBio emphasizes that Non-GLP toxicology studies are not designed to replace GLP IND-enabling toxicology studies. Instead, they can provide
More news about: HKeyBio
Jun 24, 2026, 08:00 ET Conagra Brands Kicks Off Summer with Exciting New Introductions
with seasoned chicken breast with penne pasta, celery, onion, and red bell pepper in a creamy alfredo sauce.All six items feature the GLP-1 "On Track" badge, making them easy to locate on shelf. Prices range from $3.49-$3.99.Hungry-Man: For the heartiest of appetites, Hungry-Man®
More news about: Conagra Brands, Inc.
Jun 24, 2026, 07:05 ET Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults
of food intake and greater body weight loss. About GLP-1 and Dual GLP-1/GIP AgonistsActivation of the glucagon-like peptide 1 (GLP-1) receptor has been shown to decrease glucose, reduce appetite, lower body weight, and improve
More news about: Viking Therapeutics, Inc.
Jun 23, 2026, 09:00 ET Kroger Health, Hy-Vee and Ahold Delhaize USA to Convene Industry Leaders Advancing the Future of Health at Nourishing Change
D.C is a natural next step in showing what's possible when industry leaders unite around a common purpose."As chronic disease trends, GLP-1 adoption and growing interest in food and health continue to reshape American healthcare, the Nourishing Change movement reflects a shared belief
More news about: The Kroger Co.